Cyproheptadine Hydrochloride (Page 2 of 2)
DOSAGE AND ADMINISTRATION
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.
Each 5 mL of Cyproheptadine Hydrochloride Oral Solution contains 2 mg of Cyproheptadine hydrochloride.
Although intended primarily for administration to children, the oral solution is also used for administration to adults who cannot swallow tablets.
Children
The total daily dosage for children may be calculated on the basis of body weight or body area using approximately 0.25 mg/kg/day (0.11 mg/lb/day) or 8 mg per square meter of body surface (8 mg/m2).
Age 2 to 6 years
The usual dose is 2 mg (one teaspoonful) two or three times a day, adjusted as necessary to the size and response of the patient. The dose is not to exceed 12 mg a day.
Age 7 to 14 years
The usual dose is 4 mg (two teaspoonsful) two or three times a day, adjusted as necessary to the size and response of the patient. The dose is not to exceed 16 mg a day.
Adults
The total daily dose for adults should not exceed 0.5 mg/kg/day (0.23 mg/lb/day). The therapeutic range is 4 to 20 mg a day, with the majority of patients requiring 12 to 16 mg a day. An occasional patient may require as much as 32 mg a day for adequate relief. It is suggested that dosage be initiated with 4 mg (two teaspoonsful) three times a day and adjusted according to the size and response of the patient.
HOW SUPPLIED
Cyproheptadine Hydrochloride Oral Solution, USP, 2 mg/5 mL in a yellow, peppermint-flavored vehicle, is supplied in a 473 mL (16 FL. OZ.) bottle.
Store at 20-25°C (68-77°F). Excursion permitted 15-30°C (59-86°F) [see USP Controlled Room Temperature].
Dispense in a tight, light-resistant container as defined in the USP.
NDC#39328-544-16 | 473 mL (16 FL. OZ.) |
Manufactured for:
Patrin Pharma
Skokie, IL 60076
(800) 936 3088
Rev 01.0122
PRINCIPAL DISPLAY PANEL — 473 mL Bottle Label
Rx Only
NDC
39328-544-16
Cyproheptadine
Hydrochloride
Oral Solution,
USP
2 mg/5 mL
473 mL (16 FL. OZ.)
PATRIN
PHARMA
CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride solution | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Labeler — Patrin Pharma, Inc. (806841677) |
Revised: 02/2022 Patrin Pharma, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/cyproheptadine-hydrochloride-23/page/2/